Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-019881
Filing Date
2018-01-25
Accepted
2018-01-25 17:03:56
Documents
5
Effectiveness Date
2018-01-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A d441046ddefa14a.htm DEFA14A 16729
2 GRAPHIC g441046dsp003.jpg GRAPHIC 147918
3 GRAPHIC g441046dsp004.jpg GRAPHIC 193350
4 GRAPHIC g441046dsp005.jpg GRAPHIC 82517
5 GRAPHIC g441046dsp006.jpg GRAPHIC 52945
  Complete submission text file 0001193125-18-019881.txt   675074
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-38042 | Film No.: 18548965
SIC: 2834 Pharmaceutical Preparations